New Observations on a Low‐Grade Diffusely Infiltrative Tumour, SMARCB1 Mutant, Arguing for a New Tumour Type
Alice Métais, Giorgia Antonia Simboli, Marc Barritault, Fabrice Chrétien et autres
0 citationsNeuropathology and Applied Neurobiology
Pierre Leblond
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
263Publications signalées
3761Citations signalées
6Affiliations récentes
Institutions déclarées
Domaines associés
Glioma Diagnosis and TreatmentNeuroblastoma Research and TreatmentsChildhood Cancer Survivors' Quality of LifeNeurofibromatosis and Schwannoma CasesBrain Metastases and Treatment
Publications récentes
Targeted therapies plus radiotherapy for diffuse intrinsic pontine glioma: the randomized phase 2 BIOMEDE trial
Marie‐Anne Debily, Gwénaël Le Teuff, Thomas Kergrohen, Pascale Varlet et autres
3 citationsNature Medicine
Building a new arsenal: repurposed drugs and metronomic chemotherapy against medulloblastoma
Caroline Donzé, Patricia Piris, Pierre Leblond, Mélanie Matteudi et autres
0 citationsExpert Review of Neurotherapeutics
CTP-11. Biological Medicines for Diffuse Intrinsic Pontine Gliomas (DIPG) Eradication (BIOMEDE). An International Randomized Phase II Biomarker-driven Platform Trial Comparing Three Targeted Therapies in Combination with Radiotherapy
Marie‐Anne Debily, Gwénaël Le Teuff, Thomas Kergrohen, Pascale Varlet et autres
0 citationsNeuro-Oncology
Dosing chemotherapy in children with obesity: literature review and evaluation of local practices
Pierre Leblond, Perrine Marec‐Bérard, Anthony Ceraulo, Benoît Dumont et autres
1 citationCancer Chemotherapy and Pharmacology
The UNI-AJA Project: A Feasibility Study Based on Real-World Data in French Adolescents and Young Adults with Cancer
Emmanuel Désandes, Alizée Diatchenko, Hugo Crochet, Nicolás André et autres
0 citationsJournal of Adolescent and Young Adult Oncology
P10.21.B DIFFUSE MIDLINE GLIOMA, H3 K27 AND BRAF/FGFR1 CO-ALTERED: DISTINCT BIOLOGY AND THERAPEUTIC OPPORTUNITIES
Lucie Auffret, Clifton E. Barry, Yassine Ajlil, Arnault Tauziède‐Espariat et autres
0 citationsNeuro-Oncology
P14.03.B ADDITIONAL METRONOMIC CYCLOPHOSPHAMIDE SURMOUNTS VISMODEGIB RESISTANCE IN ADULT SHH-MUTATED MEDULLOBLASTOMA WITH BONE METASTASIS: A CASE REPORT
François Bouille, Emmanuel Jouglar, Laura Rozenblum, Lucia Nichelli et autres
0 citationsNeuro-Oncology
241eP Whole genome and RNA sequencing for the selection of targeted therapy in advanced cancer patients
Ouissam Al Jarroudi, S. Boyault, Camille Léonce, Anthony Ferrari et autres
0 citationsAnnals of Oncology
Metastatic Low‐Grade Glioma Successfully Treated in a Pediatric Patient With BRAF A598_T599insI Mutation
Pierluigi Calò, Safiatou Diallo, Laetitia Lebrun, Nathalie Gilis et autres
1 citationCancer Reports
Corrigendum to “European standard clinical practice recommendations for newly diagnosed ependymoma of childhood and adolescence” [EJC Paediatr. Oncol. 5 (2025) 100227]
Alba Rubio‐San‐Simón, Timothy Ritzmann, Denise Obrecht, Martin Benesch et autres
0 citationsEJC Paediatric Oncology
3282 Pediatric localized intracranial ependymoma: survival, prognostic factors in a French multicentric retrospective study from 2000 to 2021 (NCT05151718)
Alexis Marguerit, Fatima Tensaouti, Mathilde Morisseau, Stéphanie Bolle et autres
0 citationsRadiotherapy and Oncology
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.